Antitumor effects of zerumbone from Zingiber zerumbet in P-388D1 cells in vitro and in vivo

Guan Cheng Huang, Ting Yi Chien, Lih Geeng Chen, Ching Chiung Wang

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The fresh rhizome of Zingiber zerumbet (L.) Roscoe ex Smith (Zingiberaceae) is widely used as a folk medicine in Taiwan. In this study, the fresh rhizome was extracted with 95 % EtOH and partitioned with diethyl ether. The antitumor effects of the diethyl ether extract were measured in cultured P-388D 1 cells and in an animal model of P-388D1-bearing CDF 1 mice. The results indicated that the extract could induce DNA fragmentation in P-388D1 cells in vitro, and significantly prolong the life of P-388D1-bearing CDF1 mice (ILS% = 127.8) at a dosage of 5 mg/kg body weight. After column chromatography combined with an MTT cytotoxicity bioassay, zerumbone, a cyclic sesquiterpene was isolated from the diethyl ether extract. Zerumbone inhibited the growth of P-388D1 cells, induced DNA fragmentation in culture, and significantly prolonged the life of P-388D1-bearing CDF1 mice (1LS% = 120.5) at a dosage of 2 mg/kg. Furthermore, zerumbone inhibited the growth of a human leukemia cell line, HL-60 cells, in a time- and concentration-dependent manner, with IC50 values of 22.29, 9.12, and 2.27 μg/mL for 6, 12, and 18 h, respectively. The cell cycle of HL-60 cells was observed after treatment with zerumbone, which induced G2/M cell cycle arrest in HL-60 cells in a time- and concentration-dependent manner, and decreased the cyclin B1/cdk 1 protein level. These results suggest that zerumbone is an active principal of Z. zerumbet and is potentially a lead compound for the development of anticancer drugs.

Original languageEnglish
Pages (from-to)219-224
Number of pages6
JournalPlanta Medica
Volume71
Issue number3
DOIs
Publication statusPublished - Mar 2005

Fingerprint

Zingiber zerumbet
Bearings (structural)
HL-60 Cells
ethyl ether
Ether
Rhizome
Cells
DNA Fragmentation
DNA fragmentation
cells
rhizomes
Zingiberaceae
G2 Phase Cell Cycle Checkpoints
mice
extracts
Lead compounds
Cyclin B1
Column chromatography
Cyclin-Dependent Kinases
Sesquiterpenes

Keywords

  • Antitumor
  • Cell cycle
  • P-388D cell
  • Zerumbone
  • Zingiber zerumbet
  • Zingiberaceae

ASJC Scopus subject areas

  • Plant Science
  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Antitumor effects of zerumbone from Zingiber zerumbet in P-388D1 cells in vitro and in vivo. / Huang, Guan Cheng; Chien, Ting Yi; Chen, Lih Geeng; Wang, Ching Chiung.

In: Planta Medica, Vol. 71, No. 3, 03.2005, p. 219-224.

Research output: Contribution to journalArticle

Huang, Guan Cheng ; Chien, Ting Yi ; Chen, Lih Geeng ; Wang, Ching Chiung. / Antitumor effects of zerumbone from Zingiber zerumbet in P-388D1 cells in vitro and in vivo. In: Planta Medica. 2005 ; Vol. 71, No. 3. pp. 219-224.
@article{f2a88b272c464549bb68dc85b627baa7,
title = "Antitumor effects of zerumbone from Zingiber zerumbet in P-388D1 cells in vitro and in vivo",
abstract = "The fresh rhizome of Zingiber zerumbet (L.) Roscoe ex Smith (Zingiberaceae) is widely used as a folk medicine in Taiwan. In this study, the fresh rhizome was extracted with 95 {\%} EtOH and partitioned with diethyl ether. The antitumor effects of the diethyl ether extract were measured in cultured P-388D 1 cells and in an animal model of P-388D1-bearing CDF 1 mice. The results indicated that the extract could induce DNA fragmentation in P-388D1 cells in vitro, and significantly prolong the life of P-388D1-bearing CDF1 mice (ILS{\%} = 127.8) at a dosage of 5 mg/kg body weight. After column chromatography combined with an MTT cytotoxicity bioassay, zerumbone, a cyclic sesquiterpene was isolated from the diethyl ether extract. Zerumbone inhibited the growth of P-388D1 cells, induced DNA fragmentation in culture, and significantly prolonged the life of P-388D1-bearing CDF1 mice (1LS{\%} = 120.5) at a dosage of 2 mg/kg. Furthermore, zerumbone inhibited the growth of a human leukemia cell line, HL-60 cells, in a time- and concentration-dependent manner, with IC50 values of 22.29, 9.12, and 2.27 μg/mL for 6, 12, and 18 h, respectively. The cell cycle of HL-60 cells was observed after treatment with zerumbone, which induced G2/M cell cycle arrest in HL-60 cells in a time- and concentration-dependent manner, and decreased the cyclin B1/cdk 1 protein level. These results suggest that zerumbone is an active principal of Z. zerumbet and is potentially a lead compound for the development of anticancer drugs.",
keywords = "Antitumor, Cell cycle, P-388D cell, Zerumbone, Zingiber zerumbet, Zingiberaceae",
author = "Huang, {Guan Cheng} and Chien, {Ting Yi} and Chen, {Lih Geeng} and Wang, {Ching Chiung}",
year = "2005",
month = "3",
doi = "10.1055/s-2005-837820",
language = "English",
volume = "71",
pages = "219--224",
journal = "Planta Medica",
issn = "0032-0943",
publisher = "Georg Thieme Verlag",
number = "3",

}

TY - JOUR

T1 - Antitumor effects of zerumbone from Zingiber zerumbet in P-388D1 cells in vitro and in vivo

AU - Huang, Guan Cheng

AU - Chien, Ting Yi

AU - Chen, Lih Geeng

AU - Wang, Ching Chiung

PY - 2005/3

Y1 - 2005/3

N2 - The fresh rhizome of Zingiber zerumbet (L.) Roscoe ex Smith (Zingiberaceae) is widely used as a folk medicine in Taiwan. In this study, the fresh rhizome was extracted with 95 % EtOH and partitioned with diethyl ether. The antitumor effects of the diethyl ether extract were measured in cultured P-388D 1 cells and in an animal model of P-388D1-bearing CDF 1 mice. The results indicated that the extract could induce DNA fragmentation in P-388D1 cells in vitro, and significantly prolong the life of P-388D1-bearing CDF1 mice (ILS% = 127.8) at a dosage of 5 mg/kg body weight. After column chromatography combined with an MTT cytotoxicity bioassay, zerumbone, a cyclic sesquiterpene was isolated from the diethyl ether extract. Zerumbone inhibited the growth of P-388D1 cells, induced DNA fragmentation in culture, and significantly prolonged the life of P-388D1-bearing CDF1 mice (1LS% = 120.5) at a dosage of 2 mg/kg. Furthermore, zerumbone inhibited the growth of a human leukemia cell line, HL-60 cells, in a time- and concentration-dependent manner, with IC50 values of 22.29, 9.12, and 2.27 μg/mL for 6, 12, and 18 h, respectively. The cell cycle of HL-60 cells was observed after treatment with zerumbone, which induced G2/M cell cycle arrest in HL-60 cells in a time- and concentration-dependent manner, and decreased the cyclin B1/cdk 1 protein level. These results suggest that zerumbone is an active principal of Z. zerumbet and is potentially a lead compound for the development of anticancer drugs.

AB - The fresh rhizome of Zingiber zerumbet (L.) Roscoe ex Smith (Zingiberaceae) is widely used as a folk medicine in Taiwan. In this study, the fresh rhizome was extracted with 95 % EtOH and partitioned with diethyl ether. The antitumor effects of the diethyl ether extract were measured in cultured P-388D 1 cells and in an animal model of P-388D1-bearing CDF 1 mice. The results indicated that the extract could induce DNA fragmentation in P-388D1 cells in vitro, and significantly prolong the life of P-388D1-bearing CDF1 mice (ILS% = 127.8) at a dosage of 5 mg/kg body weight. After column chromatography combined with an MTT cytotoxicity bioassay, zerumbone, a cyclic sesquiterpene was isolated from the diethyl ether extract. Zerumbone inhibited the growth of P-388D1 cells, induced DNA fragmentation in culture, and significantly prolonged the life of P-388D1-bearing CDF1 mice (1LS% = 120.5) at a dosage of 2 mg/kg. Furthermore, zerumbone inhibited the growth of a human leukemia cell line, HL-60 cells, in a time- and concentration-dependent manner, with IC50 values of 22.29, 9.12, and 2.27 μg/mL for 6, 12, and 18 h, respectively. The cell cycle of HL-60 cells was observed after treatment with zerumbone, which induced G2/M cell cycle arrest in HL-60 cells in a time- and concentration-dependent manner, and decreased the cyclin B1/cdk 1 protein level. These results suggest that zerumbone is an active principal of Z. zerumbet and is potentially a lead compound for the development of anticancer drugs.

KW - Antitumor

KW - Cell cycle

KW - P-388D cell

KW - Zerumbone

KW - Zingiber zerumbet

KW - Zingiberaceae

UR - http://www.scopus.com/inward/record.url?scp=16444363611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16444363611&partnerID=8YFLogxK

U2 - 10.1055/s-2005-837820

DO - 10.1055/s-2005-837820

M3 - Article

C2 - 15770541

AN - SCOPUS:16444363611

VL - 71

SP - 219

EP - 224

JO - Planta Medica

JF - Planta Medica

SN - 0032-0943

IS - 3

ER -